skip to page contentskip to sub navigation links
EyeMed Logo and Home link
Icon of a speech bubble with an eye symbol in it

Visionary

Why the eye exam for diabetics measure matters more than ever in Medicare Advantage

Why the eye exam for diabetics measure matters more than ever in Medicare Advantage
HEALTH & WELLNESS
SHARE & PRINT
November 16, 2026
Powered by EyeMed Logo

This article is intended for our Insurance Carrier Partners

As Medicare Advantage plans face increasing pressure to improve quality performance, one measure is quickly rising in importance: the Eye Exam for Diabetics (EED). CMS policy shifts have increased the relative value of the EED measure by ~23%. The reason starts with the population itself. Nearly 29% of adults age 65 and older are living with diabetes, making it one of the most common and impactful chronic conditions in Medicare.1 

 

Routine eye exams play a critical role in managing this population. Diabetic retinopathy, a leading cause of vision loss, often develops without symptoms—making early detection essential.2 

The good news: early intervention works. More than 90% of diabetes-related vision loss can be prevented with timely screening and treatment.3 

The challenge? Many members still aren’t getting the care they need. Roughly 60% of people with diabetes do not receive annual eye exams, leaving a significant gap in preventive care.3

At the same time, CMS has made changes that increase the importance of quality measures tied to preventive care and chronic condition management. As performance expectations rise, measures like EED are becoming increasingly important drivers of Star Ratings and plan success.4 That’s why leading plans are focusing not just on access, but on engagement—making it easier for members to understand their benefits, schedule care and follow through on recommended screenings.

EyeMed supports health plans in this effort through targeted outreach, provider network access and tools designed to simplify the member experience. Supporting approximately 37% of Medicare Advantage members nationwide, EyeMed brings both scale and expertise to help plans close care gaps and improve outcomes.5 

To learn more about how changes to CMS policy are impacting the EED measure—and what your plan can do to improve performance—download the full whitepaper.

 

 

 

*****

 

  1.  “National Diabetes Statistics Report”; CDC; 2026.
  2. “Diabetic retinopathy: Screening, Treatment, and Trends”; American Academy of Ophthalmology; January 2024.
  3. “Promoting Eye Health”; CDC; May 2024.
  4. “2024 Medicare Advantage Final Rule”; CMS; April 2023.
  5. EyeMed Book of Business 2025.

 

 

Why the eye exam for diabetics measure matters more than ever in Medicare Advantage